Because Spravato comes with the potential for misuse, it's only available through a restricted distribution system under a Risk Evaluation and Mitigation Strategy (REMS). Meaning, you have to go ...
The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression. Spravato is ...
Johnson & Johnson's Spravato has been approved to treat a ... we now have an option that gives patients freedom." Medical marijuana users can become addicted to pot, study says People using ...
"SPRAVATO® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral ...
Already on its way to becoming a blockbuster drug, Johnson & Johnson’s Spravato has received another potential boost as the FDA has blessed the nasal spray to be used as a monotherapy for major ...
Kelsey Warren [email protected] 609 218 4053 Investor contact: Lauren Johnson [email protected] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback